EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types

Wenyu Yang, Anqing Liu, Jian Yue, Anjie Zhu, Zhao Bi, Shufang Shi, Jinyang Liu, Jialiang Yang, Peng Yuan

Translational Oncology · 2027-01 · 75 · 103127

DOI: 10.1016/j.tranon.2026.103127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Wenyu Yang und 8 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Yang, W., Liu, A., Yue, J., Zhu, A., Bi, Z., Shi, S., Liu, J., Yang, J., & Yuan, P. (2027). PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types. Translational Oncology, 75, 103127. https://doi.org/10.1016/j.tranon.2026.103127

Vancouver

Yang W, Liu A, Yue J, Zhu A, Bi Z, Shi S, et al. PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types. Translational Oncology. 2027;75:103127. doi:10.1016/j.tranon.2026.103127

BibTeX
@article{Yang2027,
  author = {Yang, Wenyu and Liu, Anqing and Yue, Jian and Zhu, Anjie and Bi, Zhao and Shi, Shufang and Liu, Jinyang and Yang, Jialiang and Yuan, Peng},
  title = {PIRPath: A region-guided weakly supervised pathomics framework for neoadjuvant immunotherapy response prediction across multiple cancer types},
  journal = {Translational Oncology},
  year = {2027},
  volume = {75},
  pages = {103127},
  doi = {10.1016/j.tranon.2026.103127}
}
Kostenlos starten →